PRCT — PROCEPT BioRobotics Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1588978 ·
Last close
$21.25
Market Cap
$1.22B
52W High
$29.74
52W Low
$16.67
ADV30
1,639,209
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 94,498,000 | 62,379,000 | -27,390,000 | -26,861,000 | 479,352,000 | 227,914,000 | 139,282,000 |
| Mar 2026 | 83,132,000 | 53,947,000 | -32,606,000 | -31,638,000 | 487,062,000 | 245,641,000 | 139,395,000 |
| Dec 2025 | 76,383,000 | 46,313,000 | -31,041,000 | -29,845,000 | 508,081,000 | 286,503,000 | 142,211,000 |
| Sep 2025 | 83,327,000 | 54,006,000 | -23,192,000 | -21,411,000 | 511,541,000 | 294,281,000 | 131,265,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-74,340,000
Investing CF
$-10,585,000
Financing CF
$10,235,000
CapEx
$-10,585,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.94
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-700,056,000
Inventory
$77,061,000
Receivables
$107,606,000
ST Investments
—
EBIT TTM
$-106,041,000
Pretax Income TTM
$-109,514,000
Interest Exp TTM
$3,473,000
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$337,340,992
EBITDA
$-110,078,000
Free Cash Flow
$-48,970,248
Enterprise Value
$1,066,651,264
Total Cash
$227,914,000
Total Debt
$77,500,000
Shares Out
57,273,659
Trailing EPS
$-1.95
Book Value
$5.94
ROE
-30.2%
ROA
-14.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 308,054,000 | -103,859,000 | -95,572,000 | 508,081,000 | 142,211,000 | — | -48,985,000 |
| Dec 2024 | 224,498,000 | -96,614,000 | -91,413,000 | 534,017,000 | 131,797,000 | — | -99,213,000 |
| Dec 2023 | 136,191,000 | -109,170,000 | -105,897,000 | 404,717,000 | 123,965,000 | — | -108,003,000 |
| Dec 2022 | 75,014,000 | -80,724,000 | -87,154,000 | 309,329,000 | 112,257,000 | — | -80,382,000 |
TTM Snapshot
Revenues TTM
$122,489,000
NetIncome TTM
$-82,312,000
OpCashFlow TTM
$0
Assets (Latest)
$534,017,000
Forward EPS
$-1.15
Max Pain — expiry 2026-10-16
max pain strike: $25.00 · spot: $21.20 · call oi: 2,835 · put oi: 1,154
Expected Move to 2026-10-16:
±$3.83
(18.04%) —
implied range
$17.38 –
$25.03
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.30B | $16.69 | — |
| AORT | ARTIVION, INC. | $1.31B | $26.89 | — |
| IRMD | IRADIMED CORP | $1.11B | $87.18 | — |
| STVN | Stevanato Group S.p.A. | $1.11B | $22.27 | — |
| DRTS | Alpha Tau Medical Ltd. | $1.36B | $14.70 | — |
News headlines (Yahoo Finance, 1h cache)
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?
2026-08-18 22:31 · Yahoo
PROCEPT BioRobotics Q2 Earnings Call Highlights
2026-08-05 02:03 · Yahoo
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates
2026-08-04 23:00 · Yahoo
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
2026-08-04 20:05 · Yahoo
The Bull Case For PROCEPT BioRobotics (PRCT) Could Change Following Handpiece Discounting Lawsuits Learn Why
2026-07-30 03:17 · Yahoo
PROCEPT BioRobotics (PRCT) Could Be 30% Undervalued Following Class Action Scrutiny
2026-07-28 21:14 · Yahoo
Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential
2026-06-30 02:04 · Yahoo
Establishment Labs® Appoints Taylor Harris to Board of Directors
2026-06-29 12:00 · Yahoo
Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now
2026-06-25 06:02 · Yahoo
PROCEPT BioRobotics Corporation Q2 2026 Earnings Call Summary
2026-08-05 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.